Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Digipath Inc

Healthcare US DIGP

NoneUSD
0.00(0%)

Last update at 2024-11-21T21:07:50.062034Z

Day Range

--
LowHigh

52 Week Range

0.00310.04
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap2.91M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.08218M
  • Revenue TTM2.70M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 1.07M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Income before tax -2.05712M -0.68650M -2.30949M -1.80533M -1.65366M
Minority interest - - - - 0.00000M
Net income -2.05712M -0.68650M -2.30949M -1.80533M -1.65366M
Selling general administrative 2.02M 1.52M 2.27M 2.55M 2.55M
Selling and marketing expenses - - - - -
Gross profit 1.07M 0.72M 0.80M 0.84M 0.77M
Reconciled depreciation 0.20M 0.29M 0.32M 0.26M 0.28M
Ebit -1.01434M -0.77245M -1.59976M -1.74814M -1.75877M
Ebitda -1.59269M -0.24941M -1.83807M -1.47902M -1.49876M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -0.94992M -0.80061M -1.47030M -1.71250M -1.77605M
Other operating expenses - - - - 0.00000M
Interest expense 0.26M 0.14M 0.15M 0.07M 0.00000M
Tax provision - - - - -
Interest income 0.00000M 0.00093M - - -
Net interest income -0.26027M -0.14403M -0.14802M -0.06567M -
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - - - - 0.00000M
Total revenue 2.70M 2.50M 2.57M 2.55M 2.84M
Total operating expenses 3.65M 3.30M 4.04M 4.27M 4.62M
Cost of revenue 1.63M 1.79M 1.78M 1.71M 2.07M
Total other income expense net -0.84693M 0.26M -0.69116M -0.02716M 0.12M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -2.05712M -0.68650M -2.30949M -1.80533M -1.65366M
Net income applicable to common shares -2.24927M -0.68650M -2.30949M -1.80533M -1.65366M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Total assets 1.34M 1.89M 1.79M 1.36M 1.40M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets 0.05M 0.06M 0.05M 0.07M 0.07M
Total liab 4.08M 2.94M 2.88M 0.93M 0.38M
Total stockholder equity -2.74287M -1.05333M -1.08915M 0.43M 1.01M
Deferred long term liab - - - - 0.00000M
Other current liab - - 0.05M - 0.00052M
Common stock 0.08M 0.07M 0.06M 0.05M 0.04M
Capital stock 0.08M 0.07M 0.06M 0.05M 0.04M
Retained earnings -20.00877M -17.95165M -17.26515M -14.95566M -13.15033M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets - - - - 0.00000M
Cash 0.06M 0.30M 0.08M 0.32M 0.18M
Cash and equivalents - - - - -
Total current liabilities 2.95M 2.01M 0.77M 0.47M 0.38M
Current deferred revenue - - - - -
Net debt 2.43M 1.61M 1.68M 0.33M -
Short term debt - - - 0.20M 0.00000M
Short long term debt 1.92M 1.31M 0.10M 0.20M 0.00000M
Short long term debt total - - - - -
Other stockholder equity 0.07M - - - 0.00000M
Property plant equipment 0.78M 1.06M 1.39M 0.73M 0.96M
Total current assets 0.56M 0.83M 0.40M 0.63M 0.44M
Long term investments - - - - 0.00000M
Net tangible assets -2.74392M -1.05466M -1.09048M 0.42M 1.01M
Short term investments - - - 0.05M 0.03M
Net receivables 0.44M 0.45M 0.24M 0.18M 0.17M
Long term debt 0.57M 0.60M 1.66M 0.46M 0.00000M
Inventory - - - - 0.00000M
Accounts payable 0.55M 0.37M 0.39M 0.14M 0.33M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - - - 0.73M 0.96M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 0.78M 1.06M 1.39M 0.73M 0.96M
Capital lease obligations 0.33M 0.44M 0.56M - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Investments -0.66037M -0.28621M -0.34101M -0.13508M -0.20735M
Change to liabilities 0.19M -0.01474M 0.25M -0.18978M 0.20M
Total cashflows from investing activities -0.66037M -0.28621M -0.34101M -0.13508M -0.20735M
Net borrowings 0.55M 0.62M 0.72M 0.70M 0.70M
Total cash from financing activities 0.61M 0.64M 0.77M 1.32M 0.37M
Change to operating activities 0.17M 0.06M 0.09M 0.05M 0.02M
Net income -2.05712M -0.68650M -2.30949M -1.80533M -1.65366M
Change in cash -0.23976M 0.21M -0.24099M 0.15M -0.00215M
Begin period cash flow 0.30M 0.08M 0.32M 0.18M 0.18M
End period cash flow 0.06M 0.30M 0.08M 0.32M 0.18M
Total cash from operating activities -0.18479M -0.13597M -0.67161M -1.04221M -0.16340M
Issuance of capital stock 0.06M 0.02M 0.06M 0.62M 0.37M
Depreciation 0.20M 0.29M 0.32M 0.26M 0.28M
Other cashflows from investing activities -0.64265M -0.23000M -0.23000M -0.09500M -0.09500M
Dividends paid - - - - 0.00000M
Change to inventory - 0.00000M -0.03790M -0.03790M -0.03790M
Change to account receivables -0.18461M 0.06M -0.15286M -0.04716M 0.12M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities - - - - 0.00000M
Change to netincome 1.41M 0.15M 1.13M 0.66M 0.88M
Capital expenditures 0.02M 0.06M 0.14M 0.05M 0.21M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital 0.17M 0.10M 0.15M -0.18828M 0.34M
Stock based compensation 0.57M - - - -
Other non cash items 0.87M 0.26M 0.19M 0.36M 0.45M
Free cash flow -0.20251M -0.19217M -0.81276M -1.08732M -0.37076M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DIGP
Digipath Inc		 - -% - - - 1.05 11.43 1.80 -3.3581
TMO
Thermo Fisher Scientific Inc		 -0.6 0.13% 464.01 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 1.02 0.58% 178.19 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 -0.57 0.45% 126.49 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -16.36 2.91% 545.73 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas and Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. In addition, the company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. Further, its labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Digipath Inc

6450 South Cameron Street, Las Vegas, NV, United States, 89118

Key Executives

Name Title Year Born
Mr. Todd Denkin Founder & Pres 1964
Mr. A. Stone Douglass Chairman, CFO & Sec. 1948
Dr. Drazen M. Jukic M.D., Ph.D. Exec. Officer NA
Mr. Bo Deitl Consultant NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.